ATC code C08 - Reference.org

On this page

ATC code C08

Therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System: Calcium channel blockers

ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C08 is part of the anatomical group C Cardiovascular system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC08. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

We don't have any images related to ATC code C08 yet.

You can add one yourself here.

We don't have any YouTube videos related to ATC code C08 yet.

You can add one yourself here.

We don't have any PDF documents related to ATC code C08 yet.

You can add one yourself here.

We don't have any Books related to ATC code C08 yet.

You can add one yourself here.

We don't have any archived web articles related to ATC code C08 yet.

You can submit a link to a page to archive here.

C08C Selective calcium channel blockers with mainly vascular effects

C08CA Dihydropyridine derivatives

C08CA01 Amlodipine C08CA02 Felodipine C08CA03 Isradipine C08CA04 Nicardipine C08CA05 Nifedipine C08CA06 Nimodipine C08CA07 Nisoldipine C08CA08 Nitrendipine C08CA09 Lacidipine C08CA10 Nilvadipine C08CA11 Manidipine C08CA12 Barnidipine C08CA13 Lercanidipine C08CA14 Cilnidipine C08CA15 Benidipine C08CA16 Clevidipine C08CA17 Levamlodipine C08CA51 Amlodipine and celecoxib C08CA55 Nifedipine, combinations

C08CX Other selective calcium channel blockers with mainly vascular effects

C08CX01 Mibefradil

C08D Selective calcium channel blockers with direct cardiac effects

C08DA Phenylalkylamine derivatives

C08DA01 Verapamil C08DA02 Gallopamil C08DA03 Etripamil C08DA51 Verapamil, combinations

C08DB Benzothiazepine derivatives

C08DB01 Diltiazem

C08E Non-selective calcium channel blockers

C08EA Phenylalkylamine derivatives

C08EA01 Fendiline C08EA02 Bepridil

C08EX Other non-selective calcium channel blockers

C08EX01 Lidoflazine C08EX02 Perhexiline

C08G Calcium channel blockers and diuretics

C08GA Calcium channel blockers and diuretics

C08GA01 Nifedipine and diuretics C08GA02 Amlodipine and diuretics

References

"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html ↩
"Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. https://www.who.int/tools/atc-ddd-toolkit/atc-classification ↩
"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/ ↩
"ATC/DDD Index 2022: code C08". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=C08 ↩
"ATCvet Index 2022: code QC08". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=C08 ↩